A critical breakthrough in cancer investigation is arising with the use of nanobodies to reactivate damaged p53. This crucial tumor protector protein is frequently disabled in many forms of tumors, causing uncontrolled https://opensocialfactory.com/story27299367/mini-antibodies-revive-tumor-suppressor-p53-the-potential-pathway-for-malignant-management